Quantcast

Latest Roswell Park Cancer Institute Stories

2009-05-18 08:00:00

NCCN recently updated the NCCN Guidelines for Central Nervous System (CNS) Cancers. Important new updates include the recommendation to use bevacizumab as a single agent for recurrent glioblastoma multiforme in CNS cancers, the integration of a patient's Karnofsky Performance Status (KPS) score into treatment decisions, and an adjusted age range for adjuvant therapy options in patients with low grade gliomas. FORT WASHINGTON, Pa., May 18 /PRNewswire-USNewswire/ -- The National...

2009-05-18 07:00:00

Preclinical Study is Subject of Upcoming ASCO Presentation BELLEVUE, Wash., May 18 /PRNewswire/ -- Light Sciences Oncology, Inc. (LSO) today announced that a new preclinical study has yielded evidence that the company's novel light-activated drug Aptocine(TM) (formerly Litx(TM)) may enhance anti-tumor immunity and prevent metastases. Results of the study will be presented in a poster session at the annual American Society of Clinical Oncology (ASCO) meeting in Orlando, Florida, on May 30,...

2009-05-07 08:00:00

ATLANTA and BUFFALO, N.Y., May 7 /PRNewswire/ -- Roswell Park Cancer Institute (RPCI) is the first center in New York state to install Elekta's Leksell Gamma Knife(R) Perfexion(TM), an advanced radiosurgery device specifically designed to treat one or more lesions in the head in a single session. An alternative to open-brain surgery and daily radiation treatments, Gamma Knife Perfexion uses focused doses of radiation, without making a single incision, to treat brain tumors, as well as other...

2009-04-29 08:00:00

The NCCN Oncology Research Program (ORP) nears the $20 million mark in total funding and enhances its current model to include funding for therapeutics in development as well as those already FDA-approved. The ORP draws on the expertise of investigators at 21 of the world's leading cancer centers (NCCN Member Institutions) in order to advance therapeutic options for patients with cancer FORT WASHINGTON, Pa., April 29 /PRNewswire-USNewswire/ -- The National Comprehensive Cancer Network (NCCN)...

2009-03-16 09:00:00

New updates to the NCCN Clinical Practice Guidelines in Oncology(TM) for Ovarian Cancer were presented at the NCCN 14th Annual Conference on March 14. Notable additions to the NCCN Guidelines are a section on managing allergic reactions to chemotherapy agents and new agents for recurrence therapy. Robert J. Morgan, MD, of City of Hope Comprehensive Cancer Center presented the updated NCCN Guidelines that continue to stress early detection of ovarian cancer and the enrollment of patients...

2009-03-16 08:00:00

A roundtable led by Clifford Goodman, PhD, at the NCCN 14th Annual Conference, presented various views on "Finding and Achieving Value in Cancer Care." The panel of experts tackled the spectrum of issues related to defining value, and the concern that the benefit to patients of some of the latest cancer treatments may not warrant their costs. HOLLYWOOD, Fla., March 16 /PRNewswire-USNewswire/ -- Oncology is an area of rapid growth, both in terms of technological innovation and costs in...

2009-03-13 13:34:00

New updates to the NCCN Guidelines for Pancreatic Adenocarcinoma were announced on March 12 at the NCCN 14th Annual Conference. Notable additions include updates on when a laparoscopy may be beneficial to patients, clarification on diagnostic imaging protocols, and an overall emphasis on systemic therapy in all disease stages. Pancreatic adenocarcinoma is the second most common cause of death from gastrointestinal cancer. HOLLYWOOD, Fla., March 13 /PRNewswire-USNewswire/ -- The National...

2009-03-13 08:00:00

Minimally-invasive oncologic surgery procedures can be beneficial, but physicians need to be prudent when recommending the option to their patient according to Thomas A. D'Amico, MD, of Duke Comprehensive Cancer Center. Dr. D'Amico detailed the benefits and controversies of minimally invasive alternatives as well as emerging techniques including natural orifice surgery at the NCCN 14th Annual Conference. HOLLYWOOD, Fla., March 13 /PRNewswire-USNewswire/ -- Cutting-edge surgery with...

2009-03-12 14:09:00

A roundtable dedicated to cancer survivorship at the NCCN 14th Annual Conference highlighted the need for transition care plans and improved physician/patient communication for cancer survivors. Sam Donaldson of ABC News moderated the lively discussion between cancer advocates, survivors, and clinicians that touched upon the host of issues cancer survivors face upon the completion of treatment. The NCCN Annual Conference has achieved record attendance this year with more than 1600 registered...

2009-02-18 08:00:00

NCCN announces new modifications to the NCCN Guidelines for Colon and Rectal Cancers. Important additions include a new survivorship section, new indications for cetuximab as it relates to KRAS gene testing, and recommendations on how to re-evaluate patients initially presenting with unresectable disease. Colorectal cancer remains the third most frequently diagnosed cancer in men and women in the United States FORT WASHINGTON, Pa., Feb. 18 /PRNewswire-USNewswire/ -- The National...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related